Cambridge Investment Research Advisors’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
223,563
+3,402
+2% +$180K 0.03% 595
2026
Q1
$11.6M Buy
220,161
+34,440
+19% +$1.82M 0.03% 561
2025
Q4
$9.81M Buy
185,721
+18,706
+11% +$990K 0.03% 589
2025
Q3
$8.87M Buy
167,015
+72,688
+77% +$3.85M 0.02% 622
2025
Q2
$5M Sell
94,327
-5,589
-6% -$294K 0.02% 854
2025
Q1
$5.28M Buy
99,916
+80,999
+428% +$4.29M 0.02% 777
2024
Q4
$998K Buy
18,917
+14,591
+337% +$773K ﹤0.01% 1876
2024
Q3
$229K Sell
4,326
-147
-3% -$7.77K ﹤0.01% 3039
2024
Q2
$237K Buy
+4,473
New +$236K ﹤0.01% 2896

Other funds holding CLOI

Cambridge Investment Research Advisors's CLOI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its VanEck CLO ETF (CLOI) stake by 1.5% in Q2 2026, buying an estimated $180K and bringing the position to 223,563 shares worth $11.8M. The position accounts for 0.03% of the portfolio, ranked #595.

Cambridge Investment Research Advisors first reported a position in CLOI in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • Cambridge Investment Research Advisors held 223,563 shares of VanEck CLO ETF worth $11.8M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,402 VanEck CLO ETF shares in Q2 2026, an estimated $180K.
  • VanEck CLO ETF made up 0.03% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #595 holding.
  • Cambridge Investment Research Advisors first reported a position in VanEck CLO ETF in Q2 2024 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.